Catherine J. Gregory

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

Thomas R. E. Barnes, Richard Drake, Carol Paton et al. · Journal of Psychopharmacology · 2019 · 574 citations · Full text

Evidence-based Guidelines, Psychotropic Medication, Psychopharmacology +20

Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study

Sophie Holmes, Rainer Hinz, Silke Conen et al. · Biological Psychiatry · 2017 · 337 citations · Full text

Suicidal Thinking, Psychopathology, Psychiatry +14

In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study

Sophie Holmes, Rainer Hinz, Richard Drake et al. · Molecular Psychiatry · 2016 · 97 citations · Full text

Neuroimaging Biomarkers, Brain Microglial Activity, Vivo Imaging +10

Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)

Alice Egerton, Anna Murphy, J Donocik et al. · Schizophrenia Bulletin · 2020 · 94 citations · Full text

Psychotropic Medication, Psychopharmacology, Neuropsychiatry +18

Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis

Silke Conen, Catherine J. Gregory, Rainer Hinz et al. · Molecular Psychiatry · 2020 · 61 citations · Full text